Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Sponsored
Interactive Tools
Learning Modules
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Julio Chavez, MD, Moffitt Cancer Center
home
Articles
Treatment of R/R DLBCL: Beyond CAR T Therapy
September 22nd 2020
Phase 2B SADAL Trial in R/R DLBCL
September 22nd 2020
RE-MIND Study in R/R DLBCL
September 22nd 2020
L-MIND Study in R/R DLBCL
September 22nd 2020
CAR T in Transplant-Eligible and Transplant-Ineligible DLBCL
September 22nd 2020
Standard of Care for Relapsed/Refractory DLBCL
September 22nd 2020
Novel Therapies: R2-GDP-GOTEL and Smart Start
July 17th 2020
Novel Treatment Combinations for R/R DLBCL
July 17th 2020
Relapsed/Refractory DLBCL: Unmet Needs
July 17th 2020
Emerging Treatments for Relapsed/Refractory DLBCL
July 17th 2020
SADAL Trial Regimen FDA Approval
July 17th 2020
SADAL Trial Overview
July 17th 2020
CAR T-Cell Therapy Clinical Trials
July 17th 2020
CAR T-Cell Therapy Response Rates
July 17th 2020
CAR T Cell Therapy in Relapsed/Refractory DLBCL
July 17th 2020
Relapsed/Refractory DLBCL Treatment Landscape
July 17th 2020
R/R DLBCL: Transplant Eligibility and R-CHOP
July 17th 2020
Newly Diagnosed DLBCL: Treatment Decision Factors
July 17th 2020
DLBCL Risk Assessment and Genetic Signatures
July 17th 2020
Therapy Initiation Prior to Cytogenetic Testing Results
July 17th 2020